1. Delirium vs. Dementia: The Critical Distinction The most heavily tested concept is differentiating these two conditions.Delirium is an acute, rapid-onset syndrome characterized by an impaired, fluctuating level of consciousness. It is a temporary, reversible condition caused by underlying physiological issues like infections, drug toxicity, withdrawal, or metabolic imbalances.Dementia is a gradual, insidious, and progressive disease marked by cognitive decline. Crucially, the patient's level of consciousness remains intact.2. Delirium: Must-Know Clinical KnowledgeSafety Priority: Patients have poor judgment, sensory misperceptions (illusions and hallucinations), and unpredictable mood shifts. Protecting the patient from physical injury is the highest priority. Use restraints only as a last resort because they can increase agitation.Nursing Actions: Provide frequent reality orientation. Keep the environment well-lit and low-stimulus to minimize misperceptions and sensory overload. Validate the patient's fears, but never reinforce their hallucinations.Pharmacology: Treat the underlying cause first. Haloperidol may be used for severe agitation, while benzodiazepines should be avoided (except in alcohol withdrawal) because they can worsen delirium.3. Dementia: Must-Know Clinical KnowledgeCore Deficits: Remember the 4 A's: Amnesia (memory loss), Aphasia (language deterioration), Apraxia (loss of motor function execution), and Agnosia (inability to recognize objects).Types: Alzheimer's disease is the most common. Vascular dementia has an abrupt onset with a stepwise decline. Lewy Body dementia features prominent visual hallucinations. Frontotemporal dementia presents early with drastic personality changes.Nursing Actions: Establish familiar, consistent daily routines to minimize demand on memory. Monitor basic physiological needs (nutrition, hydration, toileting), as patients eventually lose the ability to perceive internal cues.Caregiver Strain: Caring for dementia patients causes severe exhaustion. Assessing caregivers for role strain and referring them to support groups or respite care is a major nursing responsibility.4. Must-Know MedicationsCholinesterase Inhibitors (Donepezil, Rivastigmine, Galantamine) and NMDA Antagonists (Memantine) temporarily slow disease progression but are not cures. Monitor for GI bleeding, nausea, and diarrhea. Newer IV infusions (Lecanemab, Donanemab) target beta-amyloid plaques but are not first-line.Safety Red Flag: Antipsychotics used to manage dementia-related psychosis carry a black box warning due to an increased mortality risk in older adults.5. Must-Know Therapeutic CommunicationEarly Dementia: Use reminiscence therapy (recalling past events). It is highly effective for boosting self-esteem because remote memory stays intact longer than recent memory. Provide single-step instructions.Severe Dementia: Do not use reality orientation if it causes the patient distress. Instead, use:Distraction: Shift their attention to a neutral activity.Going Along: Reassure the patient without correcting their delusion.
Jul 6
54 min
Disruptive behavior disorders involve an inability to regulate emotions and behaviors, resulting in persistent anger, hostility, and aggression. Mastering this material requires distinguishing the three primary diagnoses: Oppositional Defiant Disorder (ODD), Intermittent Explosive Disorder (IED), and Conduct Disorder (CD).1. Oppositional Defiant Disorder (ODD)Core Feature: An enduring pattern of defiant, disobedient, and hostile behavior toward authority figures, without major antisocial violations.Key Characteristics: Individuals show reduced sensitivity to rewards and punishments, impaired decision-making, and low self-concept. ODD is highly comorbid with ADHD, anxiety, and mood disorders. Early onset increases the risk of developing conduct disorder or antisocial personality disorder later in life.Treatment Focus: Medications do not treat ODD directly, though they can manage comorbidities like ADHD. Treatment centers on parent management training: parents learn to ignore maladaptive behaviors, reward positive behaviors, and apply strict, consistent consequences for defiance. Adolescents heavily benefit from the Coping Power Program.2. Intermittent Explosive Disorder (IED)Core Feature: Repeated, impulsive episodes of violent behavior, aggression, or angry verbal outbursts lasting less than 30 minutes.Key Characteristics: The rage is grossly out of proportion to the stressor or trigger. Crucially, the individual often feels profound embarrassment, guilt, and remorse after the episode ends. It is strongly linked to childhood trauma, frontal lobe dysfunction, and serotonin imbalances.Treatment Focus: Unlike ODD, IED is treated with medication. SSRIs like fluoxetine (Prozac) reduce aggressive tendencies by targeting underlying serotonin deficiencies. Mood stabilizers like lithium and anticonvulsants (valproic acid, phenytoin, topiramate, oxcarbazepine) are also utilized alongside CBT and anger management.3. Conduct Disorder (CD)Core Feature: The most prevalent of these disorders, characterized by persistent behaviors that violate societal norms, rules, laws, and the rights of others.Key Characteristics: Causes significant impairment in social, academic, and occupational functioning. CD crosses the line from simple defiance (ODD) into severe rights violations.Related Impulse Control DisordersKleptomania: Impulsive theft of items not needed for personal use; the patient experiences high tension beforehand and relief or exhilaration during the act.Pyromania: Intentional fire setting driven by a fascination with fire and tension relief, not for revenge or financial gain.The 20% You Must Know: ODD is severe defiance toward authority without violating the rights of others, treated primarily via behavioral parent training. CD is a severe escalation that violates laws and the basic rights of others. IED involves disproportionate, explosive aggression lasting under 30 minutes, followed by intense remorse, and is actively treated with SSRIs and mood stabilizers.
Jul 6
27 min
1. Attention-Deficit/Hyperactivity Disorder (ADHD) Diagnosis: A persistent pattern of inattention, hyperactivity, and impulsivity impacting academic and social life. It affects 9% of school-aged children, and symptoms persist into adulthood for 60% of cases. Females often present with less noticeable inattentive behaviors and are diagnosed later. Expected Findings: Short attention span, high distractibility, labile moods, inability to sit still, excessive talking, and impulsive actions without perceiving harm. Priority Interventions:Safety First: Stop unsafe behavior immediately and provide close supervision.Milieu Management: Provide a quiet environment free from distractions for task completion.Communication: Gain full attention (eye contact) before speaking. Give instructions slowly, use concrete language, and break complex tasks into small steps.Family Education: Emphasize a structured daily routine. Teach parents to balance correcting behavior with praising the child's strengths. Must-Know Medications:Stimulants (Methylphenidate, Amphetamines): NCLEX Alert: Monitor for insomnia, appetite suppression, and weight loss/growth delays. Give tablets after meals and ensure the last dose is in the early afternoon.SNRIs (Atomoxetine): Second-line treatment. Monitor for liver damage and decreased appetite.Antihypertensives (Clonidine, Guanfacine): Monitor for hypotension, dizziness, and syncope.2. Autism Spectrum Disorder (ASD) Diagnosis: A continuum characterized by severe impairment of reciprocal social interaction, communication deviance, and restricted stereotypical behaviors. It is four times more prevalent in males and usually identified by 18 months to 3 years of age. Expected Findings: Avoidance of eye contact, lack of pretend play, delayed speech, obsessive interests, and distress over minor routine changes. Look for stereotyped motor behaviors (e.g., hand flapping, body twisting, head banging). Priority Interventions:Safety: Protect the child from self-injury during tantrums or head banging; short-term inpatient care may be needed for crises.Milieu Management: Provide a safe, consistent environment, minimizing noise and lighting. Use accommodations like ear plugs for sensory integration.Therapies: Applied behavior analysis (ABA) is used in natural settings to encourage desired behaviors. Must-Know Medications: No meds exist for ASD itself. Antipsychotics treat aggressiveness/tantrums, while SSRIs mitigate repetitive behaviors.3. Other High-Yield ConditionsIntellectual Developmental Disorder: Below-average intellectual functioning (IQ <70) with impaired communication and self-care.Tourette’s Disorder: Multiple motor tics and vocal tics (e.g., echolalia) lasting over a year. Treated with atypical antipsychotics.Enuresis: Repeated voiding of urine. NCLEX Alert: Treated with imipramine (an antidepressant causing urinary retention) or desmopressin.
Jul 6
55 min
1. Core Pathophysiology Somatic illnesses revolve around somatization: unconsciously transferring mental stress into actual bodily symptoms. The most critical concept is that clients genuinely experience these symptoms; they are not faking it. Symptoms lack an organic basis, are driven by psychological conflicts, and are completely outside conscious control. Clients often suffer from alexithymia (the inability to identify emotions) and internalize stress. Their behavior is reinforced by primary gains (internal anxiety relief) and secondary gains (external attention, avoiding chores).2. Must-Know DisordersSomatic Symptom Disorder: Unexplained physical symptoms (often severe pain) consuming time and causing immense distress.Functional Neurologic Symptom Disorder (Conversion Disorder): Sudden sensory or motor deficits (e.g., blindness, paralysis). A hallmark sign is la belle indifférence—an unexpected lack of concern regarding their severe functional loss.Illness Anxiety Disorder (Hypochondriasis): Severe preoccupation or fear of having a life-threatening disease, misinterpreting normal bodily sensations.3. Critical Distinctions (Conscious vs. Unconscious) Unlike somatic illnesses, the following conditions involve conscious fabrications:Malingering: Faking physical symptoms for external incentives (e.g., money, avoiding work, evading police).Factitious Disorder (Munchausen): Intentionally producing symptoms solely to gain attention and assume the "sick role". Factitious disorder imposed on another (by proxy) involves harming someone else for "hero" status.4. Priority Nursing InterventionsRule Out Medical First: The highest safety risk is missing a true medical crisis. Never assume a new physical complaint is psychosomatic; always ensure a full medical evaluation.Do Not Argue: Never tell clients "it's all in your head". Validate their discomfort instead: "I know you are not feeling well, but it's important to get some exercise".Limit Secondary Gains: After medical evaluation, minimize discussion of the physical symptoms. If they persist, withdraw attention and redirect the conversation to their emotional feelings. Do not grant special privileges or excuse them from normal responsibilities.Teach Coping: Use emotion-focused (deep breathing, guided imagery) and problem-focused (role-playing, conflict resolution) techniques.5. Medications & Treatment Focus on managing chronic symptoms. Avoid narcotic analgesics for pain due to dependence risks. SSRIs (fluoxetine, sertraline, paroxetine) are heavily used to treat underlying anxiety and depression. Cognitive-behavioral therapy effectively improves coping. Progress is slow; success is marked by fewer medical visits and better functioning.
Jul 6
46 min
SUD is a chronic, progressive illness characterized by remissions and relapses. The highest-yield concepts for safe nursing care revolve around recognizing life-threatening withdrawal, overdose management, administering essential medications, and addressing maladaptive family dynamics.1. Must-Know Substances & Safety RisksAlcohol: A central nervous system depressant. Alcohol withdrawal is life-threatening and usually begins 4 to 12 hours after the last drink. Symptoms include tremors, elevated vital signs, sweating, and anxiety, which can progress to seizures or delirium tremens. Detoxification requires medical supervision and assessment tools like the CIWA-AR to monitor symptom severity.Opioids: Includes heroin, illicit fentanyl, and prescription medications. Intoxication causes lethargy, respiratory depression, and constricted pupils. Overdose leads to coma and death. Unlike alcohol, opioid withdrawal (aching, nausea, diarrhea, insomnia) is highly distressing but not life-threatening.Sedatives & Hypnotics: Withdrawal is severe. Abruptly stopping barbiturates can cause coma and death; these medications must be safely tapered.Stimulants (Cocaine & Methamphetamines): Intoxication causes euphoria, tachycardia, and hypertension. Withdrawal causes "crashing," severe dysphoria, and a high risk for suicide.2. Must-Know MedicationsBenzodiazepines (Lorazepam, Chlordiazepoxide, Diazepam): The gold standard for safe alcohol and sedative withdrawal; administered via tapering or symptom-triggered dosing.Thiamine (Vitamin B1): Given to clients with alcohol use disorder to prevent or treat neurologic damage like Wernicke-Korsakoff syndrome.Disulfiram (Antabuse): Deters drinking. Ingesting alcohol (even hidden sources like mouthwash or extracts) causes severe flushing, a throbbing headache, and vomiting.Naloxone (Narcan): An opioid antagonist that reverses toxicity and respiratory depression; may require repeated doses.Methadone & Buprenorphine/Naloxone: Opioid substitutes used for maintenance; they meet the physical need or block cravings without producing a high.3. Nursing Priorities & CommunicationDetox is the priority: Focus on immediate safety, nutrition, fluids, and sleep.Defense Mechanisms: Clients frequently use denial and rationalization. Nurses must focus on the "here and now," not allow blaming, and consistently redirect clients to take personal responsibility.Family Dynamics: SUD is a family illness. Nurses must teach families to avoid codependence (maladaptive coping patterns) and enabling (behaviors that seem helpful but actually allow the client to avoid the consequences of substance use).4. Dual Diagnosis & Impaired Nurses Up to 75% of individuals with severe mental illness have a co-occurring SUD, requiring integrated treatment. Additionally, nurses have higher rates of substance use than the general public due to access. Warning signs include incorrect drug counts or clients reporting ineffective pain relief. Nurses have an ethical and legal duty to report suspected colleague impairment.
Jul 6
54 min
1. Major Depressive Disorder (MDD)Core Concept: Requires ≥2 weeks of sad mood or anhedonia + ≥4 symptoms (weight/sleep changes, fatigue, guilt, poor concentration, suicidal thoughts).Priority Nursing: Directly assess suicide risk (plan, lethality, access). Promote ADLs by breaking tasks into small, concrete steps. Avoid being overly cheerful; use silence and active listening to build trust.Medications:SSRIs (Fluoxetine, Sertraline): First-line. Side effects: sexual dysfunction, weight changes.TCAs (Amitriptyline): High risk of lethality in overdose. Watch for anticholinergic side effects and orthostatic hypotension.MAOIs (Phenelzine): Risk of fatal hypertensive crisis with tyramine. Requires 5-6 week washout before starting SSRIs to prevent Serotonin Syndrome.Serotonin Syndrome: Life-threatening emergency causing confusion, hyperthermia, tachycardia, and muscle rigidity.2. Bipolar Disorder (Mania)Core Concept: Mania involves ≥1 week of elevated/irritable mood, decreased sleep, pressured speech, flight of ideas, grandiosity, and high-risk behaviors.Priority Nursing: Set firm, nonjudgmental limits on intrusive behaviors to protect boundaries. Decrease environmental stimuli. Provide high-calorie, high-protein finger foods because manic patients will not sit down to eat.Medications:Lithium: Narrow therapeutic index (maintenance 0.5-1.0 mEq/L, toxic >1.5 mEq/L). Early toxicity: N/V, diarrhea, weakness. Severe toxicity: ataxia, confusion, seizures. Patients must maintain consistent dietary salt and fluid (2L/day) intake.Anticonvulsants: Valproic acid (monitor liver), Carbamazepine (monitor WBCs for agranulocytosis), Lamotrigine (monitor for rashes).3. Suicide Risk & EmergenciesWarning Signs: Giving away prized possessions, indirect statements ("I can't take it anymore"), or sudden calmness (indicating a decision to die has been made).Priority Nursing: Assume an authoritative role to keep the patient safe. Implement 1-to-1 constant observation for high-lethality risk. Remove hazardous items like belts and shoelaces.Critical Red Flag: Suicide risk significantly increases during the first few weeks of starting antidepressants. The drug provides the physical energy to carry out a suicide plan before the depressed mood actually improves.4. Clinical Judgment & Exam LogicSafety First: Always assess suicidal ideation directly; do not ignore subtle hints.Communication: Avoid clichés ("things will get better"). Acknowledge and validate feelings. For mania, use short, simple sentences.ECT: Induces a therapeutic seizure. Safe for pregnant women/elderly. Post-ECT, expect mild confusion and short-term memory impairment.
Jul 6
51 min
1. Core Concept & Presentation Schizophrenia alters thought, perception, and behavior. It stems from genetic and neurochemical imbalances, primarily excess dopamine and serotonin. • Positive Symptoms: Additions to normal behavior, including delusions (fixed false beliefs), hallucinations (false sensory perceptions), and disordered speech like word salad or echolalia. • Negative Symptoms: Deficits in behavior, including flat affect, anhedonia (lack of joy), alogia (poverty of speech), and avolition (lack of motivation). These symptoms are major barriers to daily functioning.2. Must-Know Safety Red Flags (Psychiatric Emergencies) • Command Hallucinations: Voices demanding the patient harm themselves or others. The nurse must explicitly ask what the voices are saying to initiate safety precautions. • Neuroleptic Malignant Syndrome (NMS): A fatal antipsychotic reaction causing muscle rigidity, high fever, leukocytosis, and increased CPK. The absolute priority is to stop the medication immediately and notify the physician. • Agranulocytosis: Clozapine can cause a fatal drop in white blood cells. Monitor Absolute Neutrophil Count (ANC) weekly; immediately report fever, malaise, or sore throat. • Extrapyramidal Symptoms (EPS): Includes acute dystonia (airway-compromising muscle spasms), pseudoparkinsonism, and akathisia (severe restlessness). Treat emergently with intramuscular benztropine or diphenhydramine. • Tardive Dyskinesia (TD): Late, irreversible involuntary movements like lip-smacking or tongue protrusion. Assess routinely using the AIMS (Abnormal Involuntary Movement Scale) tool. • Suicide Risk: 10% of people with schizophrenia die by suicide; assessing suicidal ideation is a top priority.3. Must-Know Pharmacology • Conventional (Typical): Haloperidol, Chlorpromazine. Target only positive symptoms by blocking dopamine. High risk of EPS. • Atypical: Risperidone, Olanzapine, Clozapine. Target both positive and negative symptoms. • Long-Acting Injections (LAIs): Used for chronic medication nonadherence, but never used for acute psychotic episodes because they take weeks to reach stable dosing.4. Therapeutic Communication & Interventions • For Delusions: Never argue with, openly confront, or validate the false belief. Present reality simply ("I have seen no evidence of that") and use distraction techniques. • For Hallucinations: Do not pretend the hallucination is real. Say, "I don't see anything, but you must be frightened". Engage the patient in reality-based activities (like playing cards) to compete with the hallucinations. • For Bizarre Behavior: Redirect the patient matter-of-factly away from public areas to protect their dignity without scolding. Give agitated patients ample personal space to avoid escalating fear.5. NCLEX Exam Logic • Priority Action: Safety is always first. If a patient is hallucinating, first ask what the voices are commanding. • Medication Alerts: NMS = rigidity + fever (Stop med); EPS = spasms (Give benztropine); Clozapine = sore throat (Check ANC).
Jul 6
44 min
1. Medication Name and Class Haloperidol (Haldol) is a high-potency first-generation (conventional) antipsychotic structurally related to droperidol.2. Mechanism of Action Haloperidol blocks central postsynaptic dopamine (D-2) receptors in the mesolimbic pathway, which treats positive symptoms of schizophrenia like hallucinations and delusions. However, dopamine blockade in the nigrostriatal pathway causes extrapyramidal symptoms (EPS), while blockade in the tuberoinfundibular tract causes hyperprolactinemia. It has weak affinity for muscarinic, alpha-1, and H-1 receptors, meaning it causes less sedation, reflex tachycardia, and orthostatic hypotension compared to other antipsychotics.3. Indications FDA-approved uses include schizophrenia, Tourette's disorder, severe behavioral disorders in children, and acute agitation. Off-label uses include ICU delirium, persistent hiccups, chemotherapy-induced nausea, and severe behavioral symptoms of dementia.4. Boxed Warning and Geriatric Precautions Haloperidol carries a Boxed Warning regarding its use in geriatric patients with dementia-related psychosis. It is not FDA-approved for this population due to an increased risk of mortality, primarily from heart failure, sudden death, and infections like pneumonia. Additionally, there is an increased risk of cerebrovascular adverse events, including fatal strokes and transient ischemic attacks. The Beers Criteria considers it potentially inappropriate for elderly patients except in specific cases like schizophrenia or chemotherapy-induced nausea. Use for dementia behavioral symptoms must meet strict federal OBRA guidelines, primarily when the patient is a substantial threat to self or others. Due to the risk of hyponatremia and SIADH, sodium levels should be monitored closely.5. Pharmacokinetics and Administration Oral formulations should be taken with food to minimize GI irritation. Oral concentrates can be mixed with food or beverages, but not coffee or tea, which cause precipitation. Nurses should avoid skin contact with the concentrate to prevent contact dermatitis. Intramuscular (IM) lactate is an immediate-release injection that peaks in 20 to 40 minutes. Max adult dose is 20 mg/day. Intramuscular (IM) decanoate is a depot injection in sesame oil used for prolonged therapy. It must be administered deep IM, never IV, with a maximum of 3 mL per site using a 21-gauge needle. Peak concentrations occur after about 6 days, and the half-life is roughly 3 weeks. Patients must be stabilized on oral haloperidol before converting to the depot formulation. Intravenous (IV) administration of haloperidol is not FDA-approved in any population. If used off-label (e.g., for ICU delirium), it carries a high risk of QT prolongation, Torsade de Pointes (TdP), and arrhythmias, requiring strict ECG monitoring.6. Major Adverse Effects Severe, life-threatening adverse effects include neuroleptic malignant syndrome (NMS), tardive dyskinesia, QT prolongation, Torsade de Pointes, cardiac arrest, seizures, and agranulocytosis. Moderate effects include severe EPS (pseudoparkinsonism, akathisia, dystonic reactions) and hyperprolactinemia (galactorrhea, amenorrhea, impotence). Mild effects include drowsiness, dry mouth, and tremors.7. Drug Interactions and Metabolism Haloperidol is extensively metabolized in the liver by CYP2D6 and CYP3A4. Slow metabolizers of CYP2D6 are at increased risk for EPS due to delayed drug clearance. Co-administration with CYP3A4 or CYP2D6 inhibitors can increase haloperidol concentrations and the risk of QT prolongation. Avoid or reduce dosage in patients with severe hepatic impairment. No dosage adjustments are needed for renal impairment.
Jul 6
25 min
![MH PHARM | Chlorpromazine [Thorazine]](https://cdn-images.podbay.fm/eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJ1cmwiOiJodHRwczovL21lZGlhLnJzcy5jb20vc3RhdC1zdGl0Y2gtZGVlcC1kaXZlLXBvZGNhc3QtYmV5b25kLXRoZS1iZWRzaWRlL2VwX2NvdmVyXzIwMjYwNzA2XzA4MDc1Nl9iNTFjNjc4ZGJlNTg4MTJkYzhkZTJhNDU2NTg1NDViMS5wbmciLCJmYWxsYmFjayI6Imh0dHBzOi8vaXMxLXNzbC5tenN0YXRpYy5jb20vaW1hZ2UvdGh1bWIvUG9kY2FzdHMyMTEvdjQvMWEvZWEvMTgvMWFlYTE4ZDItNWNhMy03NjAxLTM5YjctZDRlYWJmOTNkZGUyL216YV8xNTgxMjYyMDQ3MzM1NDU2MzQxOS5wbmcvNjAweDYwMGJiLmpwZyJ9.ZzzgSObawG-63j2YEI_u67fNs1nenSlpddTnnA9R9CI.jpg?width=200&height=200)
Chlorpromazine (Thorazine): Essential Clinical Profile1. Mechanism of Action & Pharmacology Chlorpromazine is a first-generation phenothiazine antipsychotic and antiemetic. It blocks postsynaptic dopamine D2 receptors in the mesolimbic system, reducing psychosis but causing extrapyramidal symptoms (EPS). Dopamine blockade in the chemoreceptor trigger zone produces antiemetic effects. It exhibits strong anticholinergic and alpha-1-adrenergic receptor blocking properties, causing sedation and cardiovascular effects like profound hypotension.2. Pharmacokinetics & Metabolism Oral bioavailability averages 32% due to extensive first-pass metabolism. It is 90% to 99% plasma protein-bound, and undergoes biphasic metabolism with a terminal half-life of 30 hours. Metabolism is primarily via CYP2D6, which chlorpromazine inhibits. Only 1% of the drug is excreted unchanged in urine, and it is not dialyzable. Peak antipsychotic effects may take 6 weeks to 6 months.3. Core Indications & Dosing Parameters Approved for schizophrenia (adults start at 10-25 mg PO; up to 1000 mg/day max), severe pediatric behavioral problems (ADHD), intractable hiccups, tetanus adjunct, acute intermittent porphyria, and acute nausea/vomiting. Off-label uses include acute migraines, neonatal abstinence syndrome, and ICU agitation. It is a last-line option for pregnancy-induced nausea.4. High-Risk Administration Protocols Intravenous (IV) administration is restricted to surgical nausea, severe hiccups, or tetanus. It must NEVER be injected undiluted. Dilute with 0.9% NaCl to 1 mg/mL; maximum infusion rate is 1 mg/min for adults (0.5 mg/min for children). IM injections must be given slowly and deeply into the upper outer buttock. Blood pressure monitoring is mandatory; patients must remain completely recumbent for at least 30 minutes following IM/IV doses to prevent severe orthostatic hypotension.5. Boxed Warning & Geriatric Precautions A strict Boxed Warning notes it is not approved for dementia-related psychosis in the elderly due to significantly increased mortality risks (heart failure, sudden death, infections) and stroke. The Beers Criteria classifies it as a potentially inappropriate medication (PIM) due to risks of tardive dyskinesia, falls, and anticholinergic toxicity. Long-term care use is regulated by OBRA guidelines, requiring gradual dose reduction attempts in two separate quarters in the first year.6. Major Adverse Reactions Life-threatening reactions require immediate intervention: neuroleptic malignant syndrome (NMS), tardive dyskinesia, QT prolongation, seizures, and agranulocytosis. Common effects include drowsiness, xerostomia, photosensitivity, and severe hypotension. Discontinue therapy immediately if jaundice develops. Monitor sodium closely due to SIADH risk.
Jul 6
23 min
![MH PHARM | Prolixin [Fluphenazine]](https://cdn-images.podbay.fm/eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJ1cmwiOiJodHRwczovL21lZGlhLnJzcy5jb20vc3RhdC1zdGl0Y2gtZGVlcC1kaXZlLXBvZGNhc3QtYmV5b25kLXRoZS1iZWRzaWRlL2VwX2NvdmVyXzIwMjYwNzA2XzA4MDcxNV9mZTM3NDdiM2M1Y2M3YmRkM2QwNTEwZDhkZTA1NTJlMS5wbmciLCJmYWxsYmFjayI6Imh0dHBzOi8vaXMxLXNzbC5tenN0YXRpYy5jb20vaW1hZ2UvdGh1bWIvUG9kY2FzdHMyMTEvdjQvMWEvZWEvMTgvMWFlYTE4ZDItNWNhMy03NjAxLTM5YjctZDRlYWJmOTNkZGUyL216YV8xNTgxMjYyMDQ3MzM1NDU2MzQxOS5wbmcvNjAweDYwMGJiLmpwZyJ9.dwYyM0WX0PHqgWlxhIAk1nSlEchuxQIl45FqJxUR28Y.jpg?width=200&height=200)
Medication Name/ClassGeneric/Brand: Fluphenazine / Prolixin DecanoateClass: First-Generation Antipsychotic (Phenothiazine)2. Mechanism of ActionBlocks postsynaptic D2 (dopamine) receptors in the mesolimbic system.Possesses weak anticholinergic and alpha1-adrenergic blocking effects.Strong D2 blockade reduces psychosis but directly causes extrapyramidal symptoms (EPS).3. Expected Action/Therapeutic EffectDecreases dopamine neurotransmission to control psychotic symptoms.Provides antiemetic effects by blocking the chemoreceptor trigger zone.4. IndicationsPriority Uses: Schizophrenia (maintenance and acute management).Acute agitation in psychotic disorders.Off-Label: Severe behavioral/psychological symptoms of dementia (strictly regulated by OBRA).5. PharmacokineticsOnset/Peak: Oral peaks in 2 hrs. Immediate IM peaks in 1.5-2 hrs. Depot IM/SubQ peaks in 8-10 hrs.Duration: Immediate IM lasts 6-8 hrs; Depot lasts 2-4 weeks.Metabolism: Liver; major CYP2D6 substrate and inhibitor.6. Drug-Drug InteractionsCNS depressants: Increase sedation and fall risk in the elderly.CYP2D6 substrates: Metabolism may be inhibited by fluphenazine.Food/Liquid Interaction: Oral concentrate MUST NOT be mixed with caffeine (coffee, cola), tannics (tea), or pectinates (apple juice).7. Side Effects vs Adverse EffectsCommon: EPS (pseudoparkinsonism, akathisia, dystonia), sedation, anticholinergic effects (dry mouth), orthostatic hypotension.Severe/Life-Threatening: Neuroleptic Malignant Syndrome (NMS), Tardive Dyskinesia (TD), prolonged QT/Torsade de pointes, agranulocytosis, seizures.8. Contraindications/PrecautionsContraindicated: Hepatic impairment or liver damage.Precautions: Geriatric patients (Beers Criteria) due to high risk of falls, fractures, and anticholinergic effects.9. Nursing InterventionsAdmin: Inject deeply into upper outer gluteal muscle; rotate sites. Do NOT dilute depot injections.Safety: Keep patient recumbent for 30 mins post-injection to minimize severe hypotension.Monitor: Sodium levels for SIADH risk.10. Patient EducationTake oral doses with food if GI upset occurs.Avoid spilling liquid preparations on skin/clothing.Rise slowly from sitting or lying down to manage orthostatic hypotension.11. Black Box Warning/AntidoteBBW: Increased mortality in elderly patients with dementia-related psychosis (deaths usually from heart failure, infections, or stroke).12. Nursing School Priority SummaryMust Know: Keep the patient flat for 30 minutes after injection to prevent severe hypotensive effects.Nice to Know: 10 mg of daily oral fluphenazine converts to ~12.5 mg of depot every 3 weeks.Test Trap: The oral concentrate has strict mixing rules—never mix with coffee, tea, or apple juice.Clinical Red Flag: Watch for potentially fatal NMS, TD, and blood dyscrasias.
Jul 6
20 min
Load more